The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Tunisia currently stands at 12.4%, indicating a decrease of 0.1% (-0.8%) since 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Tunisia
No matching regions
Data currently not available for this time and region, try a different time period
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Tunisia
Female CVD, cancer, diabetes or CRD
More indicators for Tunisia
Out-of-pocket expenditure PPP per capita
intl dollar265
intl dollar15
(2021)
Newborns protected against tetanus
98%
1%
(2022)
Female wasting in children
2.1%
0.3%
(2018)
Birth registration
99.9%
0.9%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
44.3%
6.6%
(2018)
Tunisia Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 12.4% | 0.1% |
| 2018 | 12.5% | 0.1% |
| 2017 | 12.6% | 0.1% |
| 2016 | 12.7% | 0.1% |
| 2015 | 12.8% | 0.1% |
| 2014 | 12.9% | 0.2% |
| 2013 | 13.1% | 0.1% |
| 2012 | 13.2% | 0.2% |
| 2011 | 13.4% | 0% |
| 2010 | 13.4% | 0.1% |
| 2009 | 13.5% | 0.2% |
| 2008 | 13.7% | 0.1% |
| 2007 | 13.8% | 0.2% |
| 2006 | 14% | 0.1% |
| 2005 | 14.1% | 0.2% |
| 2004 | 14.3% | 0.2% |
| 2003 | 14.5% | 0.2% |
| 2002 | 14.7% | 0.2% |
| 2001 | 14.9% | 0.2% |
| 2000 | 15.1% |